Skip to main content

Travere Therapeutics, Inc.

TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001438533

In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $6.00B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Travere Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
9 insiders, $67.0M in total
Insiders trading
9
Net value
−$67.0M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Travere Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Travere Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Rote William E.Chief Research Officer98,197Sep 17, 20266
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER117,066Sep 17, 20267
Inrig JulaEVP, Head of R&D & CMO100,491Sep 17, 20268
Reed Elizabeth EChief Legal Officer and GC105,389Sep 17, 20269
Dube Eric MCHIEF EXECUTIVE OFFICER432,886Sep 17, 20268
Cline Christopher R.CHIEF FINANCIAL OFFICER87,508Sep 17, 20267
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER42,353Sep 17, 20266
Meckler Jeffrey ADirector91,500Sep 11, 20263
Lyons Gary ADirector61,500Aug 19, 20263
Coughlin TimothyDirector56,250Jun 16, 20264
Baynes Roy D.Director41,500Jun 16, 20266
Brinkley Ruth WilliamsDirector29,750May 21, 20261
Squarer RonDirector39,375May 21, 20261
Orwin John ADirector39,375May 21, 20261
Bruhn Suzanne LouiseDirector32,750May 21, 20261
Poole SandraDirector34,000May 21, 20261
Aselage SteveDirector146,919May 12, 20220
Clague LauraChief Financial Officer35,655May 12, 20220
Rosenberg Noah L.Chief Medical Officer47,614Aug 17, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 17, 2026 (view filing)9:35 PM ETSep 15-162 daysRote William E.Chief Research OfficerSSale−209.0K$62.83−$13.1M−68.0%98.2K after6 lots10b5-1
Sep 17, 2026 (view filing)9:35 PM ETSep 15-172 daysHeerma PeterEVP, CHIEF COMMERCIAL OFFICERSSale−283.2K$63.06−$17.9M−70.8%117.1K after7 lots10b5-1
Sep 17, 2026 (view filing)9:33 PM ETSep 152 daysInrig JulaEVP, Head of R&D & CMOSSale−44.7K$62.34−$2.79M−30.8%100.5K after4 lots10b5-1
Sep 17, 2026 (view filing)9:32 PM ETSep 152 daysReed Elizabeth EChief Legal Officer and GCSSale−37.5K$62.34−$2.34M−26.2%105.4K after4 lots10b5-1
Sep 17, 2026 (view filing)9:31 PM ETSep 15-172 daysDube Eric MCHIEF EXECUTIVE OFFICERSSale−400.0K$63.48−$25.4M−48.0%432.9K after8 lots10b5-1
Sep 17, 2026 (view filing)9:30 PM ETSep 152 daysCline Christopher R.CHIEF FINANCIAL OFFICERSSale−50.5K$62.34−$3.15M−36.6%87.5K after4 lots10b5-1
Sep 17, 2026 (view filing)9:29 PM ETSep 152 daysCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−5.38K$62.33−$335.0K−11.3%42.4K after3 lots10b5-1
Sep 11, 2026 (view filing)4:05 PM ETSep 101 dayMeckler Jeffrey ADirectorSSale−20.0K$67.31−$1.35M−17.9%91.5K after4 lots10b5-1
Sep 3, 2026 (view filing)4:05 PM ETSep 21 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−642$66.37−$42.6K−0.5%118.0K after
Aug 19, 2026 (view filing)4:05 PM ETAug 17-182 daysLyons Gary ADirectorSSale−10.0K$63.28−$632.8K−14.0%61.5K after5 lots10b5-1
Jun 16, 2026 (view filing)Jun 124 daysBaynes Roy D.DirectorSSale−4.50K$50.00−$225.0K−9.8%41.5K after10b5-1
Jun 16, 2026 (view filing)Jun 124 daysCoughlin TimothyDirectorSSale−10.0K$50.07−$500.7K−15.1%56.3K after10b5-1
May 19, 2026 (view filing)May 154 daysCoughlin TimothyDirectorSSale−3.25K$43.49−$141.3K−5.9%52.3K after10b5-1
May 6, 2026 (view filing)May 5-61 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−2.49K$46.31−$115.4K−2.1%118.7K after2 lots10b5-1
May 6, 2026 (view filing)May 4-62 daysInrig JulaCHIEF MEDICAL OFFICERSSale−22.5K$45.15−$1.02M−16.6%113.2K after3 lots10b5-1
May 6, 2026 (view filing)May 51 dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−2.17K$46.65−$101.4K−1.5%140.7K after
May 6, 2026 (view filing)May 6Same dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−22.5K$43.95−$988.9K−4.9%432.9K after10b5-1
May 6, 2026 (view filing)May 6Same dayRote William E.Chief Research OfficerSSale−2.76K$43.95−$121.4K−2.3%115.5K after10b5-1
May 6, 2026 (view filing)May 51 dayBaynes Roy D.DirectorSSale−4.50K$46.65−$209.9K−10.7%37.5K after10b5-1
May 6, 2026 (view filing)May 42 daysMeckler Jeffrey ADirectorSSale−8.00K$45.00−$360.0K−8.4%87.5K after10b5-1
May 6, 2026 (view filing)May 4-62 daysReed Elizabeth EChief Legal Officer and GCSSale−24.3K$45.06−$1.09M−18.7%105.2K after3 lots10b5-1
May 4, 2026 (view filing)May 13 daysBaynes Roy D.DirectorSSale−9.75K$44.22−$431.1K−20.6%37.5K after10b5-1
Apr 23, 2026 (view filing)Apr 221 dayRote William E.Chief Research OfficerSSale−9.10K$39.09−$355.7K−7.4%114.0K after10b5-1
Apr 16, 2026 (view filing)Apr 142 daysCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−22.0K$41.07−$902.6K−34.2%42.4K after10b5-1
Apr 16, 2026 (view filing)Apr 142 daysBaynes Roy D.DirectorSSale−32.8K$41.29−$1.35M−46.6%37.5K after2 lots10b5-1
Apr 16, 2026 (view filing)Apr 142 daysLyons Gary ADirectorSSale−8.00K$41.07−$328.6K−12.2%57.5K after10b5-1
Apr 15, 2026 (view filing)Apr 13-152 daysCline Christopher R.CHIEF FINANCIAL OFFICERSSale−8.33K$41.91−$349.0K−6.6%116.9K after4 lots10b5-1
Apr 15, 2026 (view filing)Apr 14-151 dayInrig JulaCHIEF MEDICAL OFFICERSSale−8.23K$42.01−$345.9K−6.9%111.5K after2 lots10b5-1
Apr 15, 2026 (view filing)Apr 141 dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−7.21K$41.93−$302.5K−4.9%138.6K after
Apr 15, 2026 (view filing)Apr 15Same dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−64.0K$41.09−$2.63M−12.9%432.9K after3 lots10b5-1
Apr 15, 2026 (view filing)Apr 14-151 dayReed Elizabeth EChief Legal Officer and GCSSale−51.5K$41.29−$2.13M−32.9%105.2K after4 lots10b5-1
Apr 7, 2026 (view filing)Apr 61 dayBaynes Roy D.DirectorSSale−10.0K$33.00−$330.0K−21.1%37.5K after10b5-1
Apr 2, 2026 (view filing)Apr 11 dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−60.0K$30.93−$1.86M−12.2%432.9K after2 lots10b5-1
Apr 2, 2026 (view filing)Apr 11 dayReed Elizabeth EChief Legal Officer and GCSSale−10.0K$30.00−$300.0K−8.7%105.2K after10b5-1
Mar 18, 2026 (view filing)Mar 162 daysReed Elizabeth EChief Legal Officer and GCSSale−10.0K$28.09−$280.9K−8.7%105.2K after10b5-1
Feb 24, 2026 (view filing)Feb 204 daysDube Eric MCHIEF EXECUTIVE OFFICERSSale−60.0K$30.10−$1.81M−12.2%432.9K after10b5-1
Feb 19, 2026 (view filing)Feb 172 daysReed Elizabeth EChief Legal Officer and GCSSale−10.0K$27.83−$278.3K−8.7%105.2K after2 lots10b5-1
Feb 5, 2026 (view filing)Feb 41 dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−1.75K$32.19−$56.2K−1.5%111.2K after2 lots10b5-1
Feb 5, 2026 (view filing)Feb 41 dayInrig JulaCHIEF MEDICAL OFFICERSSale−1.78K$32.21−$57.3K−1.7%105.7K after2 lots10b5-1
Feb 5, 2026 (view filing)Feb 41 dayReed Elizabeth EChief Legal Officer and GCSSale−2.99K$32.18−$96.4K−2.8%105.2K after2 lots10b5-1
Feb 3, 2026 (view filing)Feb 3Same dayCline Christopher R.CHIEF FINANCIAL OFFICERSSale−7.24K$32.12−$232.6K−6.0%113.0K after
Feb 3, 2026 (view filing)Feb 3Same dayInrig JulaCHIEF MEDICAL OFFICERSSale−6.96K$32.12−$223.4K−6.1%107.5K after
Feb 3, 2026 (view filing)Feb 3Same dayCalvin SandraSVP, CHIEF ACCOUNTING OFFICERSSale−4.33K$32.12−$139.2K−8.1%49.1K after
Feb 3, 2026 (view filing)Feb 3Same dayHeerma PeterCHIEF COMMERCIAL OFFICERSSale−7.31K$32.12−$234.8K−5.3%131.8K after
Feb 3, 2026 (view filing)Feb 3Same dayDube Eric MCHIEF EXECUTIVE OFFICERSSale−100.1K$32.28−$3.23M−18.8%432.9K after2 lots10b5-1
Feb 3, 2026 (view filing)Feb 3Same dayRote William E.Chief Research OfficerSSale−12.4K$32.87−$409.1K−10.2%109.1K after10b5-1
Feb 3, 2026 (view filing)Feb 3Same dayReed Elizabeth EChief Legal Officer and GCSSale−7.17K$32.12−$230.5K−6.2%108.2K after
Jan 27, 2026 (view filing)Jan 23-274 daysDube Eric MCHIEF EXECUTIVE OFFICERSSale−60.0K$30.09−$1.81M−12.5%419.2K after2 lots10b5-1
Jan 21, 2026 (view filing)Jan 201 dayReed Elizabeth EChief Legal Officer and GCSSale−10.0K$27.34−$273.4K−10.0%90.3K after10b5-1
Jan 7, 2026 (view filing)Jan 5-62 daysInrig JulaCHIEF MEDICAL OFFICERSSale−2.48K$39.74−$98.4K−2.8%86.3K after2 lots10b5-1